Cargando…
Expected Evolution of COVID-19 Epidemic in France for Several Combinations of Vaccination Strategies and Barrier Measures
The outbreak of the SARS-CoV-2 virus, enhanced by rapid spreads of variants, has caused a major international health crisis, with serious public health and economic consequences. An agent-based model was designed to simulate the evolution of the epidemic in France over 2021 and the first six months...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8708137/ https://www.ncbi.nlm.nih.gov/pubmed/34960207 http://dx.doi.org/10.3390/vaccines9121462 |
_version_ | 1784622608670523392 |
---|---|
author | Pageaud, Simon Pothier, Catherine Rigotti, Christophe Eyraud-Loisel, Anne Bertoglio, Jean-Pierre Bienvenüe, Alexis Leboisne, Nicolas Ponthus, Nicolas Gauchon, Romain Gueyffier, François Vanhems, Philippe Iwaz, Jean Loisel, Stéphane Roy, Pascal |
author_facet | Pageaud, Simon Pothier, Catherine Rigotti, Christophe Eyraud-Loisel, Anne Bertoglio, Jean-Pierre Bienvenüe, Alexis Leboisne, Nicolas Ponthus, Nicolas Gauchon, Romain Gueyffier, François Vanhems, Philippe Iwaz, Jean Loisel, Stéphane Roy, Pascal |
author_sort | Pageaud, Simon |
collection | PubMed |
description | The outbreak of the SARS-CoV-2 virus, enhanced by rapid spreads of variants, has caused a major international health crisis, with serious public health and economic consequences. An agent-based model was designed to simulate the evolution of the epidemic in France over 2021 and the first six months of 2022. The study compares the efficiencies of four theoretical vaccination campaigns (over 6, 9, 12, and 18 months), combined with various non-pharmaceutical interventions. In France, with the emergence of the Alpha variant, without vaccination and despite strict barrier measures, more than 600,000 deaths would be observed. An efficient vaccination campaign (i.e., total coverage of the French population) over six months would divide the death toll by 10. A vaccination campaign of 12, instead of 6, months would slightly increase the disease-related mortality (+6%) but require a 77% increase in ICU bed–days. A campaign over 18 months would increase the disease-related mortality by 17% and require a 244% increase in ICU bed–days. Thus, it seems mandatory to vaccinate the highest possible percentage of the population within 12, or better yet, 9 months. The race against the epidemic and virus variants is really a matter of vaccination strategy. |
format | Online Article Text |
id | pubmed-8708137 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-87081372021-12-25 Expected Evolution of COVID-19 Epidemic in France for Several Combinations of Vaccination Strategies and Barrier Measures Pageaud, Simon Pothier, Catherine Rigotti, Christophe Eyraud-Loisel, Anne Bertoglio, Jean-Pierre Bienvenüe, Alexis Leboisne, Nicolas Ponthus, Nicolas Gauchon, Romain Gueyffier, François Vanhems, Philippe Iwaz, Jean Loisel, Stéphane Roy, Pascal Vaccines (Basel) Article The outbreak of the SARS-CoV-2 virus, enhanced by rapid spreads of variants, has caused a major international health crisis, with serious public health and economic consequences. An agent-based model was designed to simulate the evolution of the epidemic in France over 2021 and the first six months of 2022. The study compares the efficiencies of four theoretical vaccination campaigns (over 6, 9, 12, and 18 months), combined with various non-pharmaceutical interventions. In France, with the emergence of the Alpha variant, without vaccination and despite strict barrier measures, more than 600,000 deaths would be observed. An efficient vaccination campaign (i.e., total coverage of the French population) over six months would divide the death toll by 10. A vaccination campaign of 12, instead of 6, months would slightly increase the disease-related mortality (+6%) but require a 77% increase in ICU bed–days. A campaign over 18 months would increase the disease-related mortality by 17% and require a 244% increase in ICU bed–days. Thus, it seems mandatory to vaccinate the highest possible percentage of the population within 12, or better yet, 9 months. The race against the epidemic and virus variants is really a matter of vaccination strategy. MDPI 2021-12-10 /pmc/articles/PMC8708137/ /pubmed/34960207 http://dx.doi.org/10.3390/vaccines9121462 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Pageaud, Simon Pothier, Catherine Rigotti, Christophe Eyraud-Loisel, Anne Bertoglio, Jean-Pierre Bienvenüe, Alexis Leboisne, Nicolas Ponthus, Nicolas Gauchon, Romain Gueyffier, François Vanhems, Philippe Iwaz, Jean Loisel, Stéphane Roy, Pascal Expected Evolution of COVID-19 Epidemic in France for Several Combinations of Vaccination Strategies and Barrier Measures |
title | Expected Evolution of COVID-19 Epidemic in France for Several Combinations of Vaccination Strategies and Barrier Measures |
title_full | Expected Evolution of COVID-19 Epidemic in France for Several Combinations of Vaccination Strategies and Barrier Measures |
title_fullStr | Expected Evolution of COVID-19 Epidemic in France for Several Combinations of Vaccination Strategies and Barrier Measures |
title_full_unstemmed | Expected Evolution of COVID-19 Epidemic in France for Several Combinations of Vaccination Strategies and Barrier Measures |
title_short | Expected Evolution of COVID-19 Epidemic in France for Several Combinations of Vaccination Strategies and Barrier Measures |
title_sort | expected evolution of covid-19 epidemic in france for several combinations of vaccination strategies and barrier measures |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8708137/ https://www.ncbi.nlm.nih.gov/pubmed/34960207 http://dx.doi.org/10.3390/vaccines9121462 |
work_keys_str_mv | AT pageaudsimon expectedevolutionofcovid19epidemicinfranceforseveralcombinationsofvaccinationstrategiesandbarriermeasures AT pothiercatherine expectedevolutionofcovid19epidemicinfranceforseveralcombinationsofvaccinationstrategiesandbarriermeasures AT rigottichristophe expectedevolutionofcovid19epidemicinfranceforseveralcombinationsofvaccinationstrategiesandbarriermeasures AT eyraudloiselanne expectedevolutionofcovid19epidemicinfranceforseveralcombinationsofvaccinationstrategiesandbarriermeasures AT bertogliojeanpierre expectedevolutionofcovid19epidemicinfranceforseveralcombinationsofvaccinationstrategiesandbarriermeasures AT bienvenuealexis expectedevolutionofcovid19epidemicinfranceforseveralcombinationsofvaccinationstrategiesandbarriermeasures AT leboisnenicolas expectedevolutionofcovid19epidemicinfranceforseveralcombinationsofvaccinationstrategiesandbarriermeasures AT ponthusnicolas expectedevolutionofcovid19epidemicinfranceforseveralcombinationsofvaccinationstrategiesandbarriermeasures AT gauchonromain expectedevolutionofcovid19epidemicinfranceforseveralcombinationsofvaccinationstrategiesandbarriermeasures AT gueyffierfrancois expectedevolutionofcovid19epidemicinfranceforseveralcombinationsofvaccinationstrategiesandbarriermeasures AT vanhemsphilippe expectedevolutionofcovid19epidemicinfranceforseveralcombinationsofvaccinationstrategiesandbarriermeasures AT iwazjean expectedevolutionofcovid19epidemicinfranceforseveralcombinationsofvaccinationstrategiesandbarriermeasures AT loiselstephane expectedevolutionofcovid19epidemicinfranceforseveralcombinationsofvaccinationstrategiesandbarriermeasures AT roypascal expectedevolutionofcovid19epidemicinfranceforseveralcombinationsofvaccinationstrategiesandbarriermeasures AT expectedevolutionofcovid19epidemicinfranceforseveralcombinationsofvaccinationstrategiesandbarriermeasures |